II. Types: Medication-induced Hypersensitivity Reaction
III. Differential Diagnosis: Non-immune mediated Drug Reaction
- Medication Withdrawal (examples)
- Medication intolerance
- Significant gastrointestinal upset with Codeine
- Sensitization
- Idiosyncratic reaction (examples)
- Pseudoallergic reaction (direct Mast Cell activation)
- Intravenous Contrast anaphylactoid reaction
-
Drug Interactions
- See Cytochrome P-450
- Example: Drug Interactions with Coumadin
- Medication Overdose (examples)
- Medication toxicity (examples)
- Medication specific adverse effect (examples)
- Medication Causes of Abnormal Uterine Bleeding
- Medication Causes of Constipation
- Medication Causes of Depression
- Medication Causes of Dyspepsia
- Medication Causes of Dyspnea
- Medication Causes of Edema
- Medication Causes of Galactorrhea
- Medication Causes of Headache
- Medication Causes of Hemolytic Anemia
- Medication Causes of Hyperpigmentation
- Medication Causes of Impotence
- Medication Causes of Jaundice
- Medication Causes of Lymphadenopathy
- Medication Causes of Macrocytic Anemia
- Medication Causes of Myositis
- Medication Causes of Neutropenia
- Medication Causes of Nightmares
- Medication Causes of Phototoxic Reaction
- Medication Causes of Pruritus
IV. Risk factors: Immune-mediated Drug Reaction
- Drug Hypersensitivity Reaction to related medication
- Adults (especially women)
- Concurrent Viral Infection
- Comorbid condition
- Medications with larger more complicated structure
- Non-human Proteins
- Streptokinase
- Insulin
V. Findings: Suggestive of Drug Hypersensitivity
- See Life-Threatening Drug-Induced Rashes
- Anaphylaxis
- Angioedema
- Urticaria
-
Morbilliform rash (80% of drug rashes in adults, 35% in children)
- Occurs 4 to 21 days after onset of exposure
- See Fixed Drug Eruption
- Bullous Disease
VI. Management
- Avoid drug responsible for adverse reaction
- Consider testing for allergy if suspect immune-mediated
- Type 1 Hypersensitivity Reaction
- Skin Testing
- RAST Testing
- Type 2 Hypersensitivity Reaction
- Type 3 Hypersensitivity Reaction
- Erythrocyte Sedimentation Rate (ESR) increased
- Type 4 Hypersensitivity Reaction
- Type 1 Hypersensitivity Reaction
- Consider Desensitization to offending agent
- Consider specific agent management
VII. References
- Diasio in Goldman (2000) Cecil Medicine, p. 100-1
- Gruchalla (2003) J Allergy Clin Immunol 111:548-59 [PubMed]
- Riedl (2003) Am Fam Physician 68:1781-90 [PubMed]